Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01FHL
|
|||
| Former ID |
DIB002205
|
|||
| Drug Name |
AGN-150998
|
|||
| Indication | Macular degeneration [ICD-11: 9B78.3; ICD-10: H35.3; ICD-9: 362.5] | Phase 2 | [1] | |
| Company |
Allergan Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01397409) Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.